Velan Capital Investment Management LP Portfolio Holdings

Velan Capital Investment Management LP

  • $51.7 Million
  • Q3 2025

Velan Capital Investment Management LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $51.7 Million distributed in 51 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Heron Therapeutics, Inc. with a value of $11.2M, Protara Therapeutics, Inc. with a value of $9.3M, Rezolute, Inc. with a value of $6.97M, Inspire Md, Inc. with a value of $5.17M, and Lantheus Holdings, Inc. with a value of $3.77M.

Examining the 13F form we can see an decrease of $6.45M in the current position value, from $58.2M to 51.7M.

Velan Capital Investment Management LP is based out at Alpharetta, GA

Below you can find more details about Velan Capital Investment Management LP portfolio as well as his latest detailed transactions.

Portfolio value $51.7 Million
Healthcare: $51.7 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$131M
$11.2 Million 21.67% of portfolio
8,753,290
Q3 2025 Added 25.28%
$62.1M
$9.3 Million 17.99% of portfolio
2,139,000
Q2 2025 Added 28.25%
$385M
$6.97 Million 13.47% of portfolio
750,000
Q2 2025 Added 87.5%
$17.6M
$5.17 Million 9.99% of portfolio
2,143,698
Q3 2025 Added 137.13%
$3.64B
$3.77 Million 7.29% of portfolio
73,545
Q3 2025 New
$49.6M
$2.75 Million 5.31% of portfolio
3,120,000
Q3 2025 Added 1.96%
$940M
$2 Million 3.87% of portfolio
130,000
Q3 2025 New
$1.4B
$1.87 Million 3.61% of portfolio
32,000
Q3 2025 New
$1.15B
$1.86 Million 3.6% of portfolio
86,500
Q2 2025 New
$661M
$1.83 Million 3.54% of portfolio
205,000
Q3 2025 New
$18.8M
$1.1 Million 2.12% of portfolio
747,410
Q1 2025 New
$24.2M
$895,000 1.73% of portfolio
346,973
Q3 2025 Added 2.36%
$255M
$255,000 0.49% of portfolio
80,000
Q3 2025 Added 6.67%
$4.15B
$245,000 0.47% of portfolio
3,700
Q2 2025 New
$4.37B
$224,000 0.43% of portfolio
6,500
Q3 2025 New
$92.2M
$204,000 0.39% of portfolio
160,000
Q2 2025 Added 64.95%
$102M
$162,000 0.31% of portfolio
55,000
Q4 2024 New
$846M
$152,000 0.29% of portfolio
20,000
Q2 2025 Added 17.65%
$411M
$150,000 0.29% of portfolio
20,000
Q2 2025 Added 42.86%
$603M
$147,000 0.28% of portfolio
16,000
Q3 2025 Added 60.0%
$315M
$141,000 0.27% of portfolio
65,000
Q2 2025 Added 30.0%
$523M
$124,000 0.24% of portfolio
40,000
Q1 2025 Added 14.29%
$158M
$119,000 0.23% of portfolio
55,000
Q3 2025 Added 37.5%
$208M
$115,000 0.22% of portfolio
10,000
Q3 2025 New
$600M
$108,000 0.21% of portfolio
15,000
Q2 2025 Added 15.38%
$423M
$109,000 0.21% of portfolio
80,000
Q3 2025 Added 14.29%
$146M
$106,000 0.2% of portfolio
33,000
Q2 2025 Added 17.86%
$18.5M
$97,000 0.19% of portfolio
100,000
Q2 2025 Added 11.11%
$156M
$94,000 0.18% of portfolio
45,000
Q1 2025 Added 11.11%
$443M
$83,000 0.16% of portfolio
20,000
Q3 2025 Reduced 89.08%
$58.6M
$73,000 0.14% of portfolio
35,000
Q3 2025 Added 40.0%
$168M
$62,000 0.12% of portfolio
32,700
Q2 2025 Reduced 6.57%
$63M
$49,000 0.09% of portfolio
35,000
Q4 2024 New
Tenax Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 98.53%
Zooz Pwr LTD
-
$0 0.0% of portfolio
-
Q3 2025 New
Rapt Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 70.12%
Corbus Pharmaceuticals Hldgs
-
$0 0.0% of portfolio
-
Q3 2025 Added 3.39%
Edesa Biotech Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Abivax Sa
-
$0 0.0% of portfolio
-
Q3 2025 New
Eupraxia Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 86.1%
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 8.4%
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 11.07%
Precision Biosciences Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 0.57%
Alumis Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 41.59%

Summary

  • Portfolio
  • No. of Stocks 51
  • Current Value $51.7 Million
  • Prior Value $58.2 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 11 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email